Improved Therapy Response Assessment in Metastatic Brain Tumors

NCT03458455 · clinicaltrials.gov ↗

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Brain Metastases

Interventions

DIAGNOSTIC_TEST: Magnetic Resonance Imaging
RADIATION: Stereotactic Radiosurgery
DRUG: Ipilimumab, nivolumab or pembrolizumab

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]